Instil Bio (TIL) Competitors $31.50 +1.18 (+3.89%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$31.55 +0.05 (+0.16%) As of 09/5/2025 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TIL vs. PROK, TBPH, IMTX, ABUS, GHRS, KALV, KURA, BCAX, RLAY, and KROSShould you be buying Instil Bio stock or one of its competitors? The main competitors of Instil Bio include ProKidney (PROK), Theravance Biopharma (TBPH), Immatics (IMTX), Arbutus Biopharma (ABUS), GH Research (GHRS), KalVista Pharmaceuticals (KALV), Kura Oncology (KURA), Bicara Therapeutics (BCAX), Relay Therapeutics (RLAY), and Keros Therapeutics (KROS). These companies are all part of the "pharmaceutical products" industry. Instil Bio vs. Its Competitors ProKidney Theravance Biopharma Immatics Arbutus Biopharma GH Research KalVista Pharmaceuticals Kura Oncology Bicara Therapeutics Relay Therapeutics Keros Therapeutics ProKidney (NASDAQ:PROK) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment. Which has more risk & volatility, PROK or TIL? ProKidney has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Instil Bio has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Do insiders and institutionals hold more shares of PROK or TIL? 51.6% of ProKidney shares are held by institutional investors. Comparatively, 60.6% of Instil Bio shares are held by institutional investors. 41.5% of ProKidney shares are held by company insiders. Comparatively, 47.2% of Instil Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, PROK or TIL? ProKidney has higher revenue and earnings than Instil Bio. ProKidney is trading at a lower price-to-earnings ratio than Instil Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProKidney$80K8,276.63-$61.19M-$0.57-3.95Instil BioN/AN/A-$74.14M-$12.92-2.44 Does the media prefer PROK or TIL? In the previous week, ProKidney had 5 more articles in the media than Instil Bio. MarketBeat recorded 5 mentions for ProKidney and 0 mentions for Instil Bio. ProKidney's average media sentiment score of 0.54 beat Instil Bio's score of 0.00 indicating that ProKidney is being referred to more favorably in the media. Company Overall Sentiment ProKidney Positive Instil Bio Neutral Is PROK or TIL more profitable? ProKidney's return on equity of 0.00% beat Instil Bio's return on equity.Company Net Margins Return on Equity Return on Assets ProKidneyN/A N/A -17.11% Instil Bio N/A -54.32%-33.65% Do analysts rate PROK or TIL? ProKidney presently has a consensus target price of $6.25, suggesting a potential upside of 177.78%. Instil Bio has a consensus target price of $119.00, suggesting a potential upside of 277.78%. Given Instil Bio's stronger consensus rating and higher possible upside, analysts clearly believe Instil Bio is more favorable than ProKidney.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ProKidney 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33Instil Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryProKidney and Instil Bio tied by winning 7 of the 14 factors compared between the two stocks. Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIL vs. The Competition Export to ExcelMetricInstil BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$212.65M$3.12B$5.79B$9.92BDividend YieldN/A2.28%6.71%4.53%P/E Ratio-2.4421.1076.0826.13Price / SalesN/A229.57460.9379.98Price / CashN/A44.9736.9659.04Price / Book1.219.8711.486.09Net Income-$74.14M-$53.42M$3.29B$266.51M7 Day Performance16.67%2.93%1.27%0.45%1 Month Performance19.73%9.85%7.94%4.58%1 Year Performance121.05%15.74%62.93%26.04% Instil Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TILInstil Bio2.8916 of 5 stars$31.50+3.9%$119.00+277.8%+122.6%$212.65MN/A-2.44410Gap UpPROKProKidney3.1243 of 5 stars$2.35-2.5%$6.25+166.0%-5.1%$709.22M$80K-4.123TBPHTheravance Biopharma3.8114 of 5 stars$13.80-0.8%$21.33+54.6%+70.7%$700.53M$64.38M57.50110Trending NewsAnalyst RevisionIMTXImmatics2.2934 of 5 stars$5.23-8.1%$14.67+180.4%-45.2%$691.62M$130.13M-8.05260News CoveragePositive NewsABUSArbutus Biopharma2.2568 of 5 stars$3.50-2.5%$5.50+57.1%-6.9%$688.20M$6.17M-12.0790News CoveragePositive NewsAnalyst DowngradeGHRSGH Research2.4975 of 5 stars$13.18+0.8%$32.00+142.8%+66.4%$680.53MN/A-17.8110News CoverageKALVKalVista Pharmaceuticals4.1408 of 5 stars$12.99-3.1%$26.29+102.4%+22.9%$675.06MN/A-3.52100News CoveragePositive NewsUpcoming EarningsKURAKura Oncology4.0136 of 5 stars$7.65flat$24.10+215.0%-58.2%$664M$53.88M-3.38130News CoveragePositive NewsAnalyst ForecastBCAXBicara Therapeutics2.7945 of 5 stars$11.32-4.4%$32.25+184.9%N/A$646.03MN/A-3.5732News CoverageRLAYRelay Therapeutics2.7844 of 5 stars$3.51-4.9%$17.25+391.5%-36.5%$636.20M$8.36M-1.80330News CoverageAnalyst ForecastKROSKeros Therapeutics3.4528 of 5 stars$14.76-5.1%$30.00+103.3%-71.0%$631.97M$232.84M47.61100News CoveragePositive News Related Companies and Tools Related Companies PROK Competitors TBPH Competitors IMTX Competitors ABUS Competitors GHRS Competitors KALV Competitors KURA Competitors BCAX Competitors RLAY Competitors KROS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TIL) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TIL Stock Alerts